Clinical trial

Fluorouracil With or Without Eniluracil in Treating Patients With Advanced…

NCT00003873 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00003873
Title Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
Official title Phase III Trial Comparing a 28 Day Schedule of Daily Oral 5-FU Plus Eniluracil to Protracted Intravenous Infusion in Previously Untreated Patients With Advanced Colorectal Cancer
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
Intervention type Drug
Interventions fluorouracil, eniluracil
Enrollment 950
Start date Apr 1, 1999
Primary completion Jul 1, 2007
First posted Jul 16, 2004
Last update posted Jan 24, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies